Cancer Genetics, Inc. – a Leader in Personalized Medicine – Launches AntigenID™, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of I...
CANCER GENETICS (CGIX)
Last cancer genetics earnings: 11/19 04:16 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cancergenetics.com
Company Research
Source: GlobeNewswire
CGI’s AntigenID™ identifies neoantigens and neoantigen signatures that accelerate immuno-oncology drug identification, predict patient-specific immune therapy response, and help create personalized immuno-vaccines – the immuno-oncology therapy and drug development market is expected to grow to nearly USD $200 Billion by 2021. [1]Precision immunotherapy and personalized t-cell vaccines are predicted to become nearly 33% of the IO therapy market and AntigenID™ is expected to further solidify CGI’s position in personalized cancer treatment.CGI’s AntigenID™ helps in the precise identification of the right set of neoantigens that are potent, and will generate a robust immune response to fight and kill the tumor cells – creating this immune response, at a personalized level, is the cornerstone to personalized immune therapy. RUTHERFORD, N.J., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncolog
Show less
Read more
Impact Snapshot
Event Time:
CGIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGIX alerts
High impacting CANCER GENETICS news events
Weekly update
A roundup of the hottest topics